Health Care Screening Practices Impact Skin Cancer Diagnosis

Share this content:
Health Care Screening Practices Impact Skin Cancer Diagnosis
Health Care Screening Practices Impact Skin Cancer Diagnosis

THURSDAY, Dec. 27, 2018 (HealthDay News) -- Undergoing health care screening practices is associated with an increased likelihood of being diagnosed with skin cancer, according to a study published online Dec. 26 in JAMA Dermatology.

Aaron M. Drucker, M.D., from the University of Toronto, and colleagues examined data from 77,736 women from the Nurses' Health Study with 1,388,523 person-years of follow-up and from 39,756 men from the Health Professionals Follow-up Study with 635,319 person-years of follow-up.

The researchers observed positive correlations between various screening practices and diagnoses of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), with similar directions of association seen with melanoma. The multivariable hazard ratio associated with undergoing a physical examination was 1.46 (95 percent confidence interval [CI], 1.30 to 1.64) for BCC, 2.32 (95 percent CI, 1.41 to 3.80) for SCC, and 1.66 (95 percent CI, 0.85 to 3.22) for melanoma in the Nurses' Health Study. The results were similar in the Health Professionals Follow-up Study, with multivariable hazard ratios of 1.43 (95 percent CI, 1.26 to 1.63) for BCC, 1.85 (95 percent CI, 1.17 to 2.92) for SCC, and 1.04 (95 percent CI, 0.64 to 1.69) for melanoma in association with undergoing a physical examination.

"Previous studies have found associations between various medical conditions and skin cancer risk without accounting for detection bias; these previous publications should be considered in that light because the associations might be confounded by health screening behavior," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »